Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT02622048
Other study ID # 15209: 15/NW/0532
Secondary ID
Status Recruiting
Phase N/A
First received November 20, 2015
Last updated June 7, 2016
Start date September 2015
Est. completion date July 2017

Study information

Verified date June 2016
Source University of Manchester
Contact Lauren Stockton
Phone 07939563467
Email lauren.stockton@postgrad.manchester.ac.uk
Is FDA regulated No
Health authority United Kingdom: National Health Service
Study type Interventional

Clinical Trial Summary

The purpose of this trial is to explore parent-child interactions in parents with and without psychosis, and ascertain whether a brief (10 week) supported self-help parenting program offered to parents in their own homes can help improve parents' self-efficacy and general well-being, as well as interpretations of their parent-child relationship and child behaviour in children who are 3-10 years old.


Description:

The trial will be split into two stages.

Stage 1: Parents with no history of serious mental health problems and parents who have a history of psychosis or schizophrenia, who have children aged 3-10 years old, will take part in the Revised Five Minute Speech Sample (FMSS) and the Modified Camberwell Family Interview (CFI). They will also complete various measures looking at parental well-being, depression, anxiety and stress as well as parenting behaviours and interpretations of their child behaviour. In addition the PANSS interview will also be used. These interviews will be coded to investigate attributional patterns.

Stage 2: Parents who are experiencing psychosis, who took part in stage 1 will proceed to stage 2 if they want to. Parents will be seen weekly and take part in a guided self-help parenting intervention. This will require weekly visits over 10 weeks to the parents. During this time, symptoms, mood, general well-being and parenting behaviours will be monitored.

There will be no randomisation: all parents experiencing psychosis will receive the intervention.

Children do not attend the sessions, but it is hoped that parents practice the skills learned.


Recruitment information / eligibility

Status Recruiting
Enrollment 60
Est. completion date July 2017
Est. primary completion date July 2017
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Both
Age group 18 Years and older
Eligibility Inclusion Criteria for parents with psychotic illnesses

1. Presence of ICD-10 schizophrenia-spectrum diagnosis (F20-29).

2. Primary parental caregiver for index child. This includes 10 hours of contact time with their child.

3. Over 18 years of age.

4. Have at least one child aged 3-10 years old.

5. Identify difficulties in parenting during assessment.

6. Proficient in written and spoken English.

7. Capacity to provide informed consent.

Exclusion Criteria for parents with psychotic illnesses

1. Parents with a schizophrenia-spectrum diagnosis who have recently been discharged from acute in-patient care, and have less than four weeks of stabilisation. This will enable the individual sufficient time to readjust to living in the community and ensure symptom stabilisation before taking part in a study.

2. Parents who have no regular contact with the index child or where there is known intention for their child to be removed.

3. Parents who present with child protection of safeguarding issues.

4. Parents seeking or receiving support from services regarding child management issues.

5. Parents actively involved in other structured programmes.

Inclusion Criteria matched comparison group of parents for stage 1

The comparison group of parents will be matched for age, education, socioeconomic status and family composition where possible

1. No previous history of psychotic illnesses.

2. Primary parental caregiver for index child. This includes 10 hours of contact time with their child.

3. Over 18 years of age.

4. Have at least one child aged 3-10 years old.

5. Identify difficulties in parenting during assessment.

6. Proficient in written and spoken English.

7. Capacity to provide informed consent.

Exclusion Criteria for comparison group

1. Parents with schizophrenia-spectrum symptoms, diagnosis or history.

2. Parents who have no regular contact with the index child or where there is known intention for their child to be removed.

3. Parents seeking support from services regarding child management issues.

4. Parents actively involved in other structured programmes.

5. Parents/caregivers who do not have good working knowledge of English. They should have enough practical experience to be able to adequately use the English language to understand and respond to questions and to read and complete questionnaires.

6. Insufficient language or cognitive ability to participant fully or provide informed consent.

Study Design

Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Supportive Care


Intervention

Behavioral:
Triple P Positive Parenting Programme
10 week self-directed (guided) parenting intervention promoting self-belief, parenting confidence/self-efficacy and problem solving skills.

Locations

Country Name City State
United Kingdom The University of Manchester Manchester Lancashire

Sponsors (1)

Lead Sponsor Collaborator
University of Manchester

Country where clinical trial is conducted

United Kingdom, 

Outcome

Type Measure Description Time frame Safety issue
Primary Positive and Negative Syndrome Scale (PANSS) Assessment of parental symptoms, mood, behaviours, aswell as social performance and depression Initial Ax, Multiple Baseline Ax, Final Baseline Ax, 10 support sessions Ax, End Ax, Follow Up Ax. Ax from 0 - 16 weeks with 3 and 6 month follow up No
Primary Five Minute Speech Sample (FMSS) Assessment of Expressed Emotion using a 5 minute uninterrupted interview Initial Ax, End Ax, Follow up Ax. Ax from 0 - 16 weeks with 3 and 6 month follow up No
Primary Modified Camberwell Family Interview (CFI) In depth assessment of Expressed Emotion using a modified version of the CFI. This version is for parents of well children. Initial Ax only No
Secondary Depression, Anxiety and Stress Scale (DASS-21) Self-reported depression, anxiety and stress using a short form scale Initial Ax, Multiple Baseline Ax, Final Baseline Ax, 10 support sessions Ax, End Ax, Follow Up Ax. Ax from 0 - 16 weeks with 3 and 6 month follow up No
Secondary Warwick-Edinburgh Mental Well-being Scale (WEMWBS) Self-reported general well-being Initial Ax, Final Baseline Ax, End Ax, Follow Up Ax. Ax from 0 - 16 weeks with 3 and 6 month follow up No
Secondary Eyberg Child Behaviour Inventory (ECBI) Parents self-reported child problem behaviour Initial Ax, Final Baseline Ax, 10 support sessions Ax, End Ax, Follow Up Ax. Ax from 0 - 16 weeks with 3 and 6 month follow up No
Secondary Strengths and Difficulties Questionnaire (SDQ) Parents self-reported child behaviour assessing different aspects of behaviour, e.g.,: emotional symptoms, conduct problems, hyperactivity/inattention. Initial Ax, Final Baseline Ax, End Ax, Follow Up Ax. Ax from 0 - 16 weeks with 3 and 6 month follow up No
Secondary Parenting and Family Adjustment Scale (PAFAS) An assessment of parenting skills and family relationships. Baseline, 1, 5, 10, follow up No
See also
  Status Clinical Trial Phase
Recruiting NCT05039489 - A Study on the Brain Mechanism of cTBS in Improving Medication-resistant Auditory Hallucinations in Schizophrenia N/A
Completed NCT05321602 - Study to Evaluate the PK Profiles of LY03010 in Patients With Schizophrenia or Schizoaffective Disorder Phase 1
Completed NCT05111548 - Brain Stimulation and Cognitive Training - Efficacy N/A
Completed NCT04503954 - Efficacy of Chronic Disease Self-management Program in People With Schizophrenia N/A
Completed NCT02831231 - Pilot Study Comparing Effects of Xanomeline Alone to Xanomeline Plus Trospium Phase 1
Completed NCT05517460 - The Efficacy of Auricular Acupressure on Improving Constipation Among Residents in Community Rehabilitation Center N/A
Completed NCT03652974 - Disturbance of Plasma Cytokine Parameters in Clozapine-Resistant Treatment-Refractory Schizophrenia (CTRS) and Their Association With Combination Therapy Phase 4
Recruiting NCT04012684 - rTMS on Mismatch Negativity of Schizophrenia N/A
Recruiting NCT04481217 - Cognitive Factors Mediating the Relationship Between Childhood Trauma and Auditory Hallucinations in Schizophrenia N/A
Completed NCT00212784 - Efficacy and Safety of Asenapine Using an Active Control in Subjects With Schizophrenia or Schizoaffective Disorder (25517)(P05935) Phase 3
Completed NCT04092686 - A Clinical Trial That Will Study the Efficacy and Safety of an Investigational Drug in Acutely Psychotic People With Schizophrenia Phase 3
Completed NCT01914393 - Pediatric Open-Label Extension Study Phase 3
Recruiting NCT03790345 - Vitamin B6 and B12 in the Treatment of Movement Disorders Induced by Antipsychotics Phase 2/Phase 3
Recruiting NCT05956327 - Insight Into Hippocampal Neuroplasticity in Schizophrenia by Investigating Molecular Pathways During Physical Training N/A
Terminated NCT03209778 - Involuntary Memories Investigation in Schizophrenia N/A
Terminated NCT03261817 - A Controlled Study With Remote Web-based Adapted Physical Activity (e-APA) in Psychotic Disorders N/A
Completed NCT02905604 - Magnetic Stimulation of the Brain in Schizophrenia or Depression N/A
Recruiting NCT05542212 - Intra-cortical Inhibition and Cognitive Deficits in Schizophrenia N/A
Completed NCT04411979 - Effects of 12 Weeks Walking on Cognitive Function in Schizophrenia N/A
Terminated NCT03220438 - TMS Enhancement of Visual Plasticity in Schizophrenia N/A